Successful Treatment of Candida auris Ventriculitis
Author Information
Author(s): Kang Nayoung, Hsu Victor Yu-Ching, Bailey Charles Christopher Jr
Primary Institution: Providence St Joseph Hospital, Orange, California, USA
Hypothesis
Can intravenous liposomal amphotericin B and oral flucytosine effectively treat Candida auris ventriculitis?
Conclusion
The treatment of Candida auris ventriculitis with liposomal amphotericin B and flucytosine was successful, leading to resolution of the infection.
Supporting Evidence
- Candida auris is a rapidly emerging fungal pathogen associated with high resistance rates.
- The patient had a ventriculoperitoneal shunt, which is a risk factor for C auris infection.
- Antifungal therapy led to resolution of infection without complications.
Takeaway
A man with a serious infection caused by a fungus called Candida auris got better after doctors gave him two special medicines through an IV and by mouth.
Methodology
The patient was treated with intravenous liposomal amphotericin B and oral flucytosine after being diagnosed with Candida auris ventriculitis.
Limitations
This is a single case report, which may limit the generalizability of the findings.
Participant Demographics
A 41-year-old Asian man with multiple comorbidities.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website